Biology of gastrointestinal stromal tumors

Journal of Clinical Oncology

Volumn 22, Issue 18, 2004, Pages 3813-3825

  Corless, Christopher L ^a   Fletcher, Jonathan A ^a   Heinrich, Michael C ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN TYROSINE KINASE; ANTINEOPLASTIC AGENT; PHOSPHOTRANSFERASE; PIPERAZINE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PYRIMIDINE DERIVATIVE;

CHILDHOOD CANCER; EXON; FAMILIAL CANCER; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GENETIC SCREENING; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; WILD TYPE; CELL TRANSFORMATION; GASTROINTESTINAL TUMOR; GENETICS; MUTATION; ONCOGENE; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; STROMA CELL;

ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; GASTROINTESTINAL NEOPLASMS; HUMANS; MUTATION; ONCOGENES; PHENOTYPE; PHOSPHOTRANSFERASES; PIPERAZINES; PROGNOSIS; PYRIMIDINES; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; STROMAL CELLS;

EID: 4644312266     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.05.140     Document Type: Review

References (100)

1. Antonioli DA: Gastrointestinal autonomic nerve tumors. Expanding the spectrum of gastrointestinal stromal tumors. Arch Pathol Lab Med 113:831-833, 1989
2. Appelman HD: Smooth muscle tumors of the gastrointestinal tract. What we know now that Stout didn't know. Am J Surg Pathol 10:83-99, 1986 (suppl 1)
3. Franquemont DW: Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 103:41-47, 1995
4. Mazur MT, Clark HB: Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 7:507-519, 1983
5. Miettinen M, Virolainen M, Maarit SR: Gastrointestinal stromal tumors-Value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol 19:207-216, 1995
6. Mikhael AI, Bacchi CE, Zarbo RJ, et al: CD34 expression in stromal tumors of the gastrointestinal tract. Appl Immunohistochem 2:89-93, 1994
7. Herrera GA, Cerezo L, Jones JE, et al: Gastrointestinal autonomic nerve tumors. 'Plexosarcomas'. Arch Pathol Lab Med 113:846-853, 1989
8. Lee JR, Joshi V, Griffin JW Jr, et al: Gastrointestinal autonomic nerve tumor: Immunohistochemical and molecular identity with gastrointestinal stromal tumor. Am J Surg Pathol 25:979-987, 2001
9. Perez-Atayde AR, Shamberger RC, Kozakewich HW: Neuroectodermal differentiation of the gastrointestinal tumors in the Carney triad. An ultrastructural and immunohistochemical study. Am J Surg Pathol 17:706-714, 1993
10. Sakurai S, Fukasawa T, Chong JM, et al: Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal. Am J Pathol 154:23-28, 1999
11. Tsujimura T, Makiishi-Shimobayashi C, Lundkvist J, et al: Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal. Am J Pathol 158:817-823, 2001
12. Huizinga JD, Thuneberg L, Kluppel M, et al: W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 373:347-349, 1995
13. Hirota S, Isozaki K, Moriyama Y, et al: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580, 1998
14. Kindblom LG, Remotti HE, Aldenborg F, et al: Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152:1259-1269, 1998
15. Hornick JL, Fletcher CD: Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 117:188-193, 2002
16. Miettinen M, Sobin LH, Sarlomo-Rikala M: Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol 13:1134-1142, 2000
17. Miettinen M, Lasota J: Gastrointestinal stromal tumors-Definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438:1-12, 2001
18. Wardelmann E, Neidt I, Bierhoff E, et al: C-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant. Mod Pathol 15:125-136, 2002
19. Montgomery E, Torbenson MS, Kaushal M, et al: Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol 26:1296-1301, 2002
20. Sabah M, Leader M, Kay E: The problem with KIT: Clinical implications and practical difficulties with CD117 immunostaining. Appl Immunohistochem Mol Morphol 11:56-61, 2003
21. Suster S, Fletcher CD: Gastrointestinal stromal tumors with prominent signet-ring cell features. Mod Pathol 9:609-613, 1996
22. Shek TW, Luk IS, Loong F, et al: Inflammatory cell-rich gastrointestinal autonomic nerve tumor. An expansion of its histologic spectrum. Am J Surg Pathol 20:325-331, 1996
23. Ma CK, Amin MB, Kintanar E, et al: Immunohistologic characterization of gastrointestinal stromal tumors: A study of 82 cases compared with 11 cases of leiomyomas. Mod Pathol 6:139-144, 1993
24. Miettinen M, Sarlomo-Rikala M, Sobin LH, et al: Gastrointestinal stromal tumors and leiomyosarcomas in the colon: A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 24:1339-1352, 2000
25. Rudolph P, Gloeckner K, Parwaresch R, et al: Immunophenotype, proliferation, DNA ploidy, and biological behavior of gastrointestinal stromal tumors: A multivariate clinicopathologic study. Hum Pathol 29:791-800, 1998
26. Tworek JA, Appelman HD, Singleton TP, et al: Stromal tumors of the jejunum and ileum. Mod Pathol 10:200-209, 1997
27. Tworek JA, Goldblum JR, Weiss SW, et al: Stromal tumors of the anorectum: A clinicopathologic study of 22 cases. Am J Surg Pathol 23:946-954, 1999
28. Tworek JA, Goldblum JR, Weiss SW, et al: Stromal tumors of the abdominal colon: A clinicopathologic study of 20 cases. Am J Surg Pathol 23:937-945, 1999
29. Brainard JA, Goldblum JR: Stromal tumors of the jejunum and ileum: A clinicopathologic study of 39 cases. Am J Surg Pathol 21:407-416, 1997
30. Haque S, Dean PJ: Stromal neoplasms of the rectum and anal canal. Hum Pathol 23:762-767, 1992
31. Miettinen M, Sarlomo-Rikala M, Sobin LH, et al: Esophageal stromal tumors: A clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 24:211-222, 2000
32. Ortiz-Hidalgo C, de Leon B, Albores-Saavedra J: Stromal tumor of the gallbladder with phenotype of interstitial cells of Cajal: A previously unrecognized neoplasm. Am J Surg Pathol 24:1420-1423, 2000
33. Reith JD, Goldblum JR, Lyles RH, et al: Extragastrointestinal (soft tissue) stromal tumors: An analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol 13:577-585, 2000
34. Sakurai S, Hishima T, Takazawa Y, et al: Gastrointestinal stromal tumors and KIT-positive mesenchymal cells in the omentum. Pathol Int 51:524-531, 2001
35. Corless CL, McGreevey L, Haley A, et al: KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 160:1567-1572, 2002
36. Kindblom LG, Meis-Kindblom J, Bumming P, et al: Incidence, prevalence, phenotype and biologic spectrum of gastrointestinal stromal tumors (GIST)-A population-based study of 600 cases. Ann Oncol 13:157, 2003 (suppl 5)
37. Fletcher C, Berman J, Corless C, et al: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 33:459-465, 2002
38. DeMatteo RP, Lewis JJ, Leung D, et al: Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg 231:51-58, 2000
39. Singer S, Rubin BP, Lux ML, et al: Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 20:3898-3905, 2002
40. Amin MB, Ma CK, Linden MD, et al: Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Correlation with mitotic count and clinical outcome. Am J Clin Pathol 100:428-432, 1993
41. Cooper PN, Quirke P, Hardy GJ, et al: A flow cytometric, clinical, and histological study of stromal neoplasms of the gastrointestinal tract. Am J Surg Pathol 16:163-170, 1992
42. Emory TS, Sobin LH, Lukes L, et al: Prognosis of gastrointestinal smooth-muscle (stromal) tumors: Dependence on anatomic site. Am J Surg Pathol 23:82-87, 1999
43. Miettinen M, Kopczynski J, Makhlouf HR, et al: Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: A clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 27:625-641, 2003
44. Goldblum JR: DNA ploidy and proliferative index in gastrointestinal stromal tumors. Hum Pathol 29:102, 1998
45. Miettinen M, el-Rifai W, Sobin L, et al: Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: A review. Hum Pathol 33:478-483, 2002
46. Ng EH, Pollock RE, Munsell MF, et al: Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 215: 68-77, 1992
47. DeMatteo RP, Heinrich MC, el-Rifai W, et al: Clinical management of gastrointestinal stromal tumors: Before and after STI-571. Hum Pathol 33:466-477, 2002
48. Demetri GD: Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib. Mechanisms, successes, and challenges to rational drug development. Hematol Oncol Clin North Am 16:1115-1124, 2002
49. Miettinen M, Sarlomo-Rikala M, Kovatich AJ: Cell-type- and tumour-type-related patterns of bcl-2 reactivity in mesenchymal cells and soft tissue tumours. Virchows Arch 433:255-260, 1998
50. Plaat BEC, Hollema H, Molenaar WM, et al: Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: Differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol 18:3211-3220, 2000
51. Allander SV, Nupponen NN, Ringner M, et al: Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile. Cancer Res 61:8624-8628, 2001
52. Nielsen TO, West RB, Linn SC, et al: Molecular characterisation of soft tissue tumours: A gene expression study. Lancet 359: 1301-1307, 2002
53. Besmer P, Murphy JE, George PC, et al: A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320:415-419, 1986
54. Yarden Y, Kuang WJ, Yang-Feng T, et al: Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341-3351, 1987
55. Rousset D, Agnes F, Lachaume P, et al: Molecular evolution of the genes encoding receptor tyrosine kinase with immunoglobulinlike domains. J Mol Evol 41:421-429, 1995
56. Nocka K, Majumder S, Chabot B, et al: Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice-Evidence for an impaired c-kit kinase in mutant mice. Genes Dev 3:816-826, 1989
57. Blume-Jensen P, Claesson-Welsh L, Siegbahn A, et al: Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis. EMBO J 10:4121-4128, 1991
58. Kitayama H, Kanakura Y, Furitsu T, et al: Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85:790-798, 1995
59. Ma Y, Cunningham ME, Wang X, et al: Inhibition of spontaneous receptor phosphorylation by residues in a putative alpha-helix in the KIT intracellular juxtamembrane region. J Biol Chem 274:13399-13402, 1999
60. Chan PM, Ilangumaran S, La Rose J, et al: Autoinhibition of the kit receptor tyrosine kinase by the cytosolic juxtamembrane region. Mol Cell Biol 23:3067-3078, 2003
61. Rubin BP, Singer S, Tsao C, et al: KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 61:8118-8121, 2001
62. Ernst SI, Hubbs AE, Przygodzki RM, et al: KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest 78:1633-1636, 1998
63. Lasota J, Jasinski M, Sarlomo-Rikala M, et al: Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 154:53-60, 1999
64. Li SQ, O'Leary TJ, Sobin LH, et al: Analysis of KIT mutation and protein expression in fine needle aspirates of gastrointestinal stromal/smooth muscle tumors. Acta Cytol 44:981-986, 2000
65. Moskaluk CA, Tian Q, Marshall CR, et al: Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors. Oncogene 18:1897-1902, 1999
66. Taniguchi M, Nishida T, Hirota S, et al: Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res 59:4297-4300, 1999
67. Heinrich MC, Corless CL, Demetri GD, et al: Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21:4342-4349, 2003
68. Lux ML, Rubin BP, Biase TL, et al: KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol 156:791-795, 2000
69. Hirota S, Nishida T, Isozaki K, et al: Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours. J Pathol 193:505-510, 2001
70. Lasota J, Wozniak A, Sarlomo-Rikala M, et al: Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors: A study of 200 cases. Am J Pathol 157: 1091-1095, 2000
71. Sakurai S, Oguni S, Hironaka M, et al: Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese. Jpn J Cancer Res 92:494-498, 2001
72. Antonescu CR, Sommer G, Sarran L, et al: Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clin Cancer Res 9:3329-3337, 2003
73. Kinoshita K, Isozaki K, Hirota S, et al: C-kit gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumors. J Gastroenterol Hepatol 18:147-151, 2003
74. Hirota S, Nishida T, Isozaki K, et al: Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene. Gastroenterology 122:1493-1499, 2002
75. Gari M, Goodeve A, Wilson G, et al: C-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia. Br J Haematol 105:894-900, 1999
76. Hongyo T, Li T, Syaifudin M, et al: Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan. Cancer Res 60:2345-2347, 2000
77. Longley BJ, Tyrrell L, Lu SZ, et al: Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm. Nat Genet 12:312-314, 1996
78. Tian Q, Frierson HFJ, Krystal GW, et al: Activating c-kit gene mutations in human germ cell tumors. Am J Pathol 154:1643-1647, 1999
79. Wardelmann E, Losen I, Hans V, et al: Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors. Int J Cancer 106:887-895, 2003
80. Heinrich MC, Corless CL, Duensing A, et al: PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299:708-710, 2003
81. Hirota S, Ohashi A, Nishida T, et al: Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology 125:660-667, 2003
82. Nishida T, Hirota S, Taniguchi M, et al: Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet 19:323-324, 1998
83. Sommer G, Agosti V, Ehlers I, et al: Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase. Proc Natl Acad Sci U S A 100: 6706-6711, 2003
84. Beghini A, Tibiletti MG, Roversi G, et al: Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer 92:657-662, 2001
85. Maeyama H, Hidaka E, Ota H, et al: Familial gastrointestinal stromal tumor with hyperpigmentation: Association with a germline mutation of the c-kit gene. Gastroenterology 120:210-215, 2001
86. el Omar M, Davies J, Gupta S, et al: Leiomyosarcoma in leiomyomatosis of the small intestine. Postgrad Med J 70:661-664, 1994
87. O'Brien P, Kapusta L, Dardick I, et al: Multiple familial gastrointestinal autonomic nerve tumors and small intestinal neuronal dysplasia. Am J Surg Pathol 23:198-204, 1999
88. Hirota S, Okazaki T, Kitamura Y, et al: Cause of familial and multiple gastrointestinal autonomic nerve tumors with hyperplasia of interstitial cells of Cajal is germline mutation of the c-kit gene. Am J Surg Pathol 24:326-327, 2000
89. Isozaki K, Terris B, Belghiti J, et al: Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. Am J Pathol 157:1581-1585, 2000
90. Bergmann F, Gunawan B, Hermanns B, et al: Cytogenetic and morphologic characteristics of gastrointestinal stromal tumors. Recurrent rearrangement of chromosome 1 and losses of chromosomes 14 and 22 as common anomalies. Verh Dtsch Ges Pathol 82:275-278, 1998
91. Debiec-Rychter M, Lasota J, Sarlomo-Rikala M, et al: Chromosomal aberrations in malignant gastrointestinal stromal tumors: Correlation with c-KIT gene mutation. Cancer Genet Cytogenet 128:24-30, 2001
92. Fukasawa T, Chong JM, Sakurai S, et al: Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor. Jpn J Cancer Res 91:1241-1249, 2000
93. Heinrich MC, Rubin BP, Longley BJ, et al: Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol 33:486-495, 2002
94. Kim NG, Kim JJ, Ahn JY, et al: Putative chromosomal deletions on 9P, 9Q and 22Q occur preferentially in malignant gastrointestinal stromal tumors. Int J Cancer 85:633-638, 2000
95. el-Rifai W, Sarlomo-Rikala M, Andersson LC, et al: High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci. Genes Chromosomes Cancer 27: 387-391, 2000
96. El Rifai W, Sarlomo-Rikala M, Miettinen M, et al: DNA copy number losses in chromosome 14: An early change in gastrointestinal stromal tumors. Cancer Res 56:3230-3233, 1996
97. O'Leary T, Ernst S, Przygodzki R, et al: Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest 79:1461-1467, 1999
98. Schneider-Stock R, Boltze C, Lasota J, et al: High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J Clin Oncol 21:1688-1697, 2003
99. el-Rifai W, Sarlomo-Rikala M, Andersson LC, et al: DNA sequence copy number changes in gastrointestinal stromal tumors: Tumor progression and prognostic significance. Cancer Res 60:3899-3903, 2000
100. Duensing A, Joseph NE, Smith F, et al: Protein kinase C theta (PKCe) expression and activation in GISTs. Mod Pathol 16:11A, 2003